Injection Molding Small Complex Bioabsorbable Implants
Injection molding intricate components for medical device implantables is a difficult task on its own. Add absorbable polymer to the equation and it becomes many times more challenging. This article reviews several of the barriers to success in this area of component fabrication for implantable medical devices.
|Bioabsorbable implant with snap feature and six living hinges—Part Diameter: 14 mm|
Bioabsorbables are widely utilized for cardiovascular applications. Examples include ligation and closure of blood vessels along with absorbable drug releasing stents and grafts. Many of these devices have small, complex, 3D structures and dynamic mechanical requirements (e.g., living hinges) that can only be formed by injection molding.
Injection molding first transitions a polymer from a solid state to a semi-liquid state by heating the material above a threshold temperature. With a reduced viscosity upon turning into a liquid, the polymer can be injected (or forced) into the cavity of a mold. The process must then be reversed (i.e., the material must cool and return to a solid state) before it can be removed from the mold.
Bioabsorbable polymers can be injection molded with extremely small features and thin sections; however, this requires special equipment and consideration. Absorbable polymer should be processed at the lowest temperatures possible with the least amount of time exposed to the elevated temperatures. Each bioabsorbable will have a different temperature threshold that, when surpassed, will reverse the polymerization process resulting in monomer formation. Introducing an extra monomer into the material matrix can immediately change the mechanical properties, alter the degradation kinetics, and even make the material toxic. Conventional injection molding equipment and processes are unable to adequately perform such controlled and rapid thermal cycling.
In addition, presses need much higher injection speeds and pressures to push melted polymer through tiny nozzles and flow channels. Higher injection speeds ensure the material will fill the part before it cools. Accurate screw and barrel design and injection control are essential. Molding very small parts generally is not recommended on machines larger than 20 tons because it is difficult to control such small shot sizes, and lab machines, though small, are not usually designed for precision control of volume production.
Those that are capable of molding such small parts commonly utilize sprue and runner systems consuming 75% or more of the volume needed to produce one part. Medical grades of bioabsorbable resins can sell for upwards of $13 per gram, so the losses must be tightly controlled to minimize the effect on the bottom line.
|Injection molded bioabsorbable polymer implant|
For these reasons, specialized systems have been developed for injection molding small complex bioabsorbable parts. Medical Murray  uses a molding machine called the Sesame, which was designed and patented (U.S. No. 6,267,580) by the company for creating small complex medical devices. The machine is designed to provide fast controlled injection and short material residence time. It uses a pneumatically driven vertical plunger for plasticating and injects with a tiny horizontal plunger (1.0- to 2.5-mm diameter) driven by a linear servo motor. Total injection time can be as short as 0.02 seconds. The Sesame’s features include very low melted volume and controlled high speed and high pressure injection. This allows the molding of sub-micro size parts with complex geometric features from materials such as bioabsorbable polymers that would otherwise degrade in standard equipment. Parts have been produced on the Sesame measuring just 0.1 mm and weighing only 2.5 mg, or one-twentieth of a single pellet.
Tanner Hargens is a senior biomedical engineer and project leader for Medical Murray Inc. He is responsible for medical device engineering research and development, and specializes in implants, biomaterials, and minimally invasive procedures. Hargens also provides expertise related to commercializing medical products including patent protection and regulatory strategizing.